STAT | Reporting from the frontiers of health and medicine

Skip to Main Content

Experience STAT's journalism live at an upcoming STAT Summit

Experience STAT's journalism live at an upcoming STAT Summit

October 23, 2026

STAT Plus: Up and down the ladder: The latest comings and goings
October 23, 2026

Remembering STAT’s Helen Branswell
October 23, 2026

STAT Plus: Treasury proposes major restrictions to U.S. investment in Chinese biotech sector
October 23, 2026

STAT Plus: AI drug firm Pathos raises $237 million, pushing valuation to $3 billion
October 23, 2026

One family’s story of a life-extending medicine for pancreatic cancer
October 23, 2026

How a targeted drug kept one patient alive 15 years — but failed to save her friends

Test your knowledge with our now weekday mini crossword

Play the STAT Mini

Meet the 2026 STAT Wunderkinds

See the class of 2026

STAT reporters react to the new Elizabeth Holmes documentary

People can't stop talking about 'You Can See Everything' — our staffers share their take

Biotech October 22, 2026

STAT Plus: Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial

Biotech October 23, 2026

STAT Plus: Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer

First Opinion October 23, 2026

Overdose deaths have plunged. We need to know why

Health October 23, 2026

STAT Plus: State officials scrambling to implement Medicaid work requirements meet up to swap notes

Sponsored

Advertisement

Sign up for Newsletters

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

STAT Plus: Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial

STAT Plus: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction

STAT Plus: Mark Cuban wants to crack open the market for rare disease treatments

STAT Plus: What to expect from the Moderna-Merck cancer vaccine data reveal

STAT Plus: Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

ESMO 2026: The STAT Recap

Virtual

Behind-the-scenes insights from the annual European Society for Medical Oncology (ESMO) Congress in Madrid.

STAT@hlth. A Dose of Reality on EHRs and AI

In-person

STAT@ASH: Medicine’s Bleeding Edge

New Orleans, LA

2027 Breakthrough Summit East

New York City, NY

All Events

All Trackers

More From STAT

More From STAT

More From STAT

We create tools to help you understand and track complex areas of development.

All Trackers

Obesity Drug Tracker

Here are the dozens of weight loss drugs in development to catch a booming market.

CRISPR Tracker

Follow the latest developments in genome editing.

Generative AI Tracker

A guide to the health systems and companies driving adoption.

Breakthrough Device Tracker

An authoritative database of FDA’s fast-tracked medical devices.

All Reports

More From STAT

More From STAT

More From STAT

STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.

All Reports

Chaotic and politicized: Inside the FDA under Trump

$49

Explore how turmoil and political pressure have destabilized the agency with mass layoffs, rapid staff departures, and a revolving door of leadership.

All Podcasts

More From STAT

More From STAT

More From STAT

From policy to practice: STAT's podcasts decode health care complexities.

All Podcasts

The Readout LOUD

Our weekly biotech podcast digs deep into industry goings-on.

First Opinion Podcast

A weekly interview show featuring the most interesting people and ideas in medicine.

Color Code

Enjoy the archives of Color Code, our podcast on racial inequities in American health care.

More From STAT

View upcoming events Play the STAT Mini Crossword Explore trackers Download our latest Report Listen to STAT podcasts

More Stories

Pharmalot October 23, 2026

STAT Plus: Up and down the ladder: The latest comings and goings

The Readout LOUD October 23, 2026

Remembering STAT’s Helen Branswell

Biotech October 23, 2026

STAT Plus: Treasury proposes major restrictions to U.S. investment in Chinese biotech sector

Health tech October 23, 2026

STAT Plus: AI drug firm Pathos raises $237 million, pushing valuation to $3 billion

Health October 23, 2026

One family’s story of a life-extending medicine for pancreatic cancer

Health October 23, 2026

How a targeted drug kept one patient alive 15 years — but failed to save her friends

First Opinion October 23, 2026

New Medicare policies will keep important pain relief from some patients

Biotech October 23, 2026

STAT Plus: Alnylam says Huntington’s drug shows promise in early study

Pharmalot October 22, 2026

STAT Plus: Gilead to pay $45 million to settle kickback charges filed by Texas attorney general

Biotech October 22, 2026

STAT Plus: AbbVie skin disorder drug succeeds in late-stage trial, but results miss market expectations

Health October 22, 2026

STAT Plus: Nutrition experts press White House to release ultra-processed food definition

Politics October 22, 2026

Top MAHA adviser Calley Means resigns from White House days ahead of midterms

The Readout October 23, 2026

STAT Plus: Tango builds on Revolution Medicines’ pancreatic cancer success

Pharmalot October 23, 2026

STAT Plus: Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more

The Readout October 22, 2026

STAT Plus: Will the Treasury restrict U.S. investment in the Chinese biotech sector?

D.C. Diagnosis October 22, 2026

STAT Plus: Crackdowns loom, from China to New York

Pharmalot October 22, 2026

STAT Plus: Pharmalittle: We’re reading about a U.S. rule on Chinese deals, Belgium refusing Mounjaro coverage, and more

Biotech October 22, 2026

STAT Plus: What to expect from the Moderna-Merck cancer vaccine data reveal

First Opinion October 23, 2026

Overdose deaths have plunged. We need to know why

First Opinion October 23, 2026

New Medicare policies will keep important pain relief from some patients

First Opinion October 22, 2026

The inherited disease my family called ‘it’ had a name, which changed everything

First Opinion October 22, 2026

What I got wrong about the Affordable Care Act — and how to fix it

First Opinion October 21, 2026

How knocking on doors can help beat measles — again

First Opinion October 21, 2026

Replication is necessary even if scientists do everything right

Newsletters

Mon - Fri

Your daily dose of news in health and science

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

Helen Branswell, whose reporting on infectious diseases and public health drew acclaim, dies at 69

By Andrew Joseph

Meet the 2026 STAT Wunderkinds

By STAT Staff

STAT Plus: Can you live longer for $5,500? Longevity clinics are the buzzy new trend at nonprofit hospitals

STAT Plus: Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug

By Adam Feuerstein

STAT Plus: In Duchenne muscular dystrophy, a promising therapy is available to a fortunate few

Hospital and pharmaceutical prices are smothering America’s businesses

STAT Plus: Will MAHA survive the midterms?

By Isabella Cueto, Chelsea Cirruzzo, and Daniel Payne

A mother-daughter quest to find fellow members of an ultra-rare genetic community

By Deepa Fernandes

STAT Plus: Roivant says closely watched immune drug succeeded in new eye disease

Biotech October 21, 2026

STAT Plus: Roivant says closely watched immune drug succeeded in new eye disease

Biotech October 21, 2026

STAT Plus: A German biotech has big ambitions in cancer. Now it needs to get a medicine approved

Biotech October 19, 2026

STAT Plus: Gilead’s IBD drug eliminated symptoms for patients, mid-stage study finds

STAT Plus: Pharmalittle: We’re reading about Mark Cuban eyeing rare disease drugs, a ketamine gold rush, and more

Pharmalot October 21, 2026

STAT Plus: Pharmalittle: We’re reading about Mark Cuban eyeing rare disease drugs, a ketamine gold rush, and more

Pharmalot October 20, 2026

STAT Plus: Pharmalittle: We’re reading about drug launch prices, an AstraZeneca AI deal, and more

Pharmalot October 20, 2026

STAT Plus: Launch prices for new medicines dipped slightly last year but remain high, analysis finds

STAT Plus: Another diabetes association leader is out while review continues

Health October 21, 2026

STAT Plus: Another diabetes association leader is out while review continues

Health October 20, 2026

STAT Plus: He’s slashing quality at nursing homes. This state is letting it happen

Health October 19, 2026

Trump orders creation of NIH division, task force on women’s health

STAT Plus: CMS extends fraud crackdown to New York’s adult day care program

Politics October 21, 2026

STAT Plus: CMS extends fraud crackdown to New York’s adult day care program

Politics October 20, 2026

STAT Plus: The key health care ballot measures we’re watching in the midterms

Politics October 16, 2026

STAT Plus: In DOGE’s aftermath, federal health workers bristle at new performance reviews

Video

STAT reporters react to the new Elizabeth Holmes documentary

What are hospital longevity programs, and what can they tell you about your health?

She’s spent two decades talking to parents who don’t vaccinate their children. Here’s what she’s learned

What happens on ‘MAHA Monday’?

How consumer tech company Whoop is building for Medicare patients

Health tech October 14, 2026

How consumer tech company Whoop is building for Medicare patients

Health tech October 14, 2026

STAT Plus: Lobbyists and trade groups fight to shape how states regulate medical AI

Health tech October 8, 2026

STAT Plus: Why this startup is taking its AI to predict breast cancer risk directly to patients

STAT Plus: Cambridge scientist David Sabatini speaks out after courtroom victory: ‘The hardest years of my life’

In the Lab October 18, 2026

STAT Plus: Cambridge scientist David Sabatini speaks out after courtroom victory: ‘The hardest years of my life’

In the Lab October 16, 2026

STAT Plus: Jury rules in favor of ousted Cambridge scientist David Sabatini, with $6 million in damages to be awarded

In the Lab October 16, 2026

STAT Plus: Coerced sex or a jealous ex? Jury weighs dueling accounts of star scientist David Sabatini’s downfall

STAT Plus: Dana-Farber, Beth Israel to begin construction of new $1.68 billion cancer hospital

Hospitals October 20, 2026

STAT Plus: Dana-Farber, Beth Israel to begin construction of new $1.68 billion cancer hospital

Hospitals August 18, 2026

STAT Plus: Leaders of Mass General, Dana-Farber among hospital execs who got big raises in 2024

Hospitals July 8, 2026

STAT Plus: Mass General Brigham, nurses called to talk at State House amid biggest nursing strike in Mass.

STAT Plus: BlackRock to buy majority stake in Humana’s CenterWell clinics for $2.8 billion

Insurance October 13, 2026

STAT Plus: BlackRock to buy majority stake in Humana’s CenterWell clinics for $2.8 billion

Insurance October 9, 2026

STAT Plus: Medicare Advantage star ratings trigger new bonuses, and uncertainty

Insurance September 30, 2026

STAT Plus: UnitedHealth investor lawsuit moves forward on allegations it ‘manufactured earnings’ to hide declining profits

Podcasts

Remembering STAT’s Helen Branswell

Mistrust in science and a juicy gene-editing lawsuit

The FDA’s Overton era, and dispatches from Shanghai

Definium’s new psychedelics data, and a reprieve for international scientists